计算生物学
化学生物学
药物发现
蛋白质降解
蛋白质-蛋白质相互作用
生物
小分子
连接器
合成生物学
化学
靶蛋白
转录因子
系统生物学
蛋白质工程
生物化学
药物开发
泛素连接酶
降级(电信)
DNA连接酶
泛素
蛋白质稳定性
支架蛋白
化学基因学
细胞生物学
纳米技术
血浆蛋白结合
细菌蛋白
翻译后修饰
行动方式
生化工程
植物生物学
植物生长
作者
Carla Donderis-Fagoaga,Lidia Orea-Ordóñez,Jorge Lozano‐Juste
摘要
Targeted protein degradation (TPD) has emerged as a chemical strategy to modulate proteostasis, offering important advantages over traditional small molecules. By inducing proximity between a protein of interest (POI) and the cellular degradation machinery, protein degraders enable selective and dynamic degradation of the POI. Unlike classical small molecules (i.e. inhibitors), the event-driven mode of action of chemical degraders offers new therapeutic opportunities for previously intractable diseases. Molecular glues (MGs) and proteolysis-targeting chimeras (PROTACs) can target proteins previously considered undruggable, including those lacking catalytic activity or deep binding pockets, such as transcription factors and scaffold proteins. TPD has gained substantial attention in drug discovery, with several candidates advancing in clinical trials, validating chemically induced proximity as therapeutic strategy. However, in plants, the development of synthetic degraders remains largely unexplored. Here, we review the molecular basis of TPD, with emphasis on MGs and PROTACs. We discuss critical aspects of PROTAC design, including E3 ligase suitability, target selection, and linker optimization. We also summarize engineered tag-based systems and emerging non-proteasomal modalities. Finally, we provide a critical evaluation of the opportunities and limitations of protein degraders and provide a theoretical and practical framework to facilitate the expansion of TPD in plant biology and agriculture.
科研通智能强力驱动
Strongly Powered by AbleSci AI